logo
Top reasons Ozempic users visit the ER — and when you should go

Top reasons Ozempic users visit the ER — and when you should go

New York Post01-05-2025

Though popular weight loss jabs like Ozempic and Wegovy have been deemed safe and effective by the FDA, concerning side effects are sending some users to the ER.
A staggering one in eight adults in the US have used a GLP-1, and a study published last month in the Annals of Internal Medicine revealed how often these users develop complications that require a trip to the hospital.
The study outlined the top reasons people are seeking medical attention — and one doctor is warning about a 'Wild West' factor that could be at the root of an unexpected issue.
3 A staggering one in eight adults in the US has tried GLP-1
mbruxelle – stock.adobe.com
Using a national surveillance network, a team of researchers at Cambridge Health Alliance tracked emergency room visits linked to semaglutide in 82 different hospitals over a two-year period.
In total, semaglutide side effects resulted in 551 emergency room visits, though less than 18% led to hospitalization. Statistically speaking, this amounts to four ER visits and less than one hospitalization for every 1,000 semaglutide patients.
Of these ER visits, 70% cited gastrointestinal distress, with common complaints of nausea, vomiting, abdominal pain and diarrhea.
GLP-1 medications are notorious for triggering digestive discomfort.
Shrinking tummy, uncomfortable tummy
A recent report found that more than 30% of GLP-1 patients drop the meds after just four weeks because they suffer early side effects like nausea or other digestive problems.
These medications slow down the passage of food through the stomach, allowing people to feel fuller, longer. However, issues arise if the drugs slow down the stomach too much and, in some cases, can lead to severe gastroparesis, or stomach paralysis.
The Post previously reported that about 30% of Wegovy users have experienced diarrhea, including some who claim they've woken up in the middle of the night to discover that they've defecated in their sleep.
Of the 70% of ER visits related to GI issues, 15% required hospitalization.
'We found that it's very infrequent that semaglutide leads to very serious adverse events that would land a patient in the hospital, but that they do occur,' study author Pieter Cohen, MD, internist at Cambridge Health Alliance and associate professor of medicine at Harvard Medical School, told Health.
A surprising twist
Low blood sugar resulted in a further 16.5% of ER visits, with nearly 38% of those cases requiring hospitalization.
That one comes as a bit of surprise, since GLP-1s play a role in regulating blood sugar.
At least one doctor thinks off-brand, compounded drugs — which are typically prepared by a pharmacist and dispensed in vials, allowing patients to administer their own dosages — could be to blame.
Compounded drugs aren't regulated by the FDA and don't undergo the same level of scrutiny as FDA-approved drugs.
'It's kind of like the Wild West when it comes to medications [that] are compounded because there is no standardization,' Dr. Peminda Cabandugama, endocrinologist at Cleveland Clinic and spokesperson for The Obesity Society, told Health.
3 Of the documented ER visits, 70% cited gastrointestinal distress, with common complaints of nausea, vomiting, abdominal pain, and diarrhea.
zigres – stock.adobe.com
Other GLP-1 issues
Less common complications that resulted in hospital visits included allergic reactions, pancreatitis, and bile duct disease.
GLP-1 users have also reported experiencing vision changes, erectile dysfunction, personality changes, increased reckless behavior, and the infamous 'Ozempic butt' and 'Ozempic boobs' (sagging in all the wrong places).
Doctors have also seen other unusual complications, such as allodynia, a type of nerve pain where things that shouldn't hurt — like brushing your hair or wearing a shirt — suddenly do.
Researchers contributing to this recent study predicted that the vast majority of ER visits would be driven by GI distress; however, they were surprised at the number of cases connected to low blood sugar, as Ozempic and Wegovy have not been previously linked to hypoglycemia.
3 A number of Ozempic users have also reported to the emergency room with gallbladder inflammation — a side effect that stems from the body failing to adapt quickly enough to rapid weight loss.
nilsversemann – stock.adobe.com
Experts note that this latest study has limitations, specifically that the data is based on documentation from ER physicians who did not differentiate between patients taking Ozempic, Wegovy, or compounded semaglutide.
Despite the FDA's warning against using off-brand semaglutide compounds due to their potential 'adverse effects,' a shortage of brand-name drugs and their hefty $1,300-a-month price tag is motivating people to seek cheaper, more accessible options.
When should you go to the doctor?
While severe side effects related to GLP-1 are rare, experts suggest seeking emergency medical attention if you experience one or more of the following symptoms: fever, vomiting, and diarrhea that lasts longer than a few hours, or constipation that lasts several days and is accompanied by vomiting.
In addition, severe pain that radiates from the abdomen through the back could be a symptom of pancreatitis, which can require hospitalization.
According to Cabandugama, clinicians should ensure that patients do not have a history of pancreatitis before prescribing Ozempic or Wegovy.
'It's very important to mention that patients go to the right trained providers for weight loss, especially with all the rise of the Instagram clinics and online clinics,' explained Cabandugama.
A number of Ozempic users have also reported to the emergency room with gallbladder inflammation — a side effect that stems from the body failing to adapt quickly enough to rapid weight loss.
'Rapid weight loss causes the liver to pump out more bile and more cholesterol, both of which can lead to the formation of gallstones within the gallbladder,' pharmacist Dr. Dan explained in a viral TikTok video.
Gallbladder inflammation is characterized by enduring pain that originates in the right upper abdomen and radiates around the sides. This inflammation can be life-threatening and patients who experience these symptoms are urged to seek medical care.
For those who find themselves in the ER, it is imperative to tell providers that they are taking GLP-1 drugs.
Experts also note that side effects tend to flare up in GLP-1 patients after eating. Consuming smaller, lighter, fiber-rich meals and avoiding fatty, fried of processed foods can help mitigate these effects.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Omada Health IPO signals healthier market, avoids 'down-round' trend
Omada Health IPO signals healthier market, avoids 'down-round' trend

Yahoo

timean hour ago

  • Yahoo

Omada Health IPO signals healthier market, avoids 'down-round' trend

The IPO market is starting to feel healthier. Omada Health, a 14-year-old company providing virtual care for chronic conditions like diabetes and hypertension between office visits, closed its first trading day on Friday at $23 a share, a 21% jump from the IPO price of $19. The IPO valued the company just above $1 billion (excluding employee options), a figure that's nearly identical to Omada's last private valuation of $1 billion set in its previous VC round. The debut is one of the first among recent IPOs that was not a so-called down-round. Many of the latest public listings, including Hinge, ServiceTitan, and Reddit, priced below their private market highs, though have faired well as public companies. For founder and CEO Sean Duffy, the successful public offering validates his decision to start a company that he believed the market desperately needed. In 2011, he dropped out of Harvard Medical School after realizing that chronic illness patients required more continuous support than the existing healthcare system delivered. Before the offering, he owned 4.1% of the company, according to Omada's offering document. Other significant shareholders included Revelation Partners (10.9%), US Venture Partners (9.9%), Andreessen Horowitz (9.6%), and FMR (9.3%). Duffy told TechCrunch that over his 14-year journey as a founder, he had many harrowing moments. "I didn't think our series A was going to come together because we were working on this commercial deal that didn't materialize, and that spooked one investor," he said. "As a young business, something tries to kill you every month," he continued. "And then as the business grows, it turns into like every quarter or six months, year, two years." One of the recent challenges for many digital health businesses is navigating the "collapse" of the market post-COVID boom. Omada steered through the turbulent times by seeking new, rising markets. It recently expanded its offerings to include diet management support for GLP-1 patients.

ProZenith Launches Natural Supplement Formulated for Weight Management Support
ProZenith Launches Natural Supplement Formulated for Weight Management Support

Yahoo

time3 hours ago

  • Yahoo

ProZenith Launches Natural Supplement Formulated for Weight Management Support

U.S.-Made Product Supports General Wellness Goals with a 60-Day Refund Policy Aurora, June 06, 2025 (GLOBE NEWSWIRE) -- ProZenith recently announced the launch of its new wellness supplement developed to assist individuals in maintaining energy, focus, and mindful appetite awareness as part of a balanced and active lifestyle. Manufactured in the United States in a facility that is FDA-registered and GMP-certified, the product is now available through official online channels. ProZenith is intended for individuals pursuing support for general weight management and overall well-being. Its formulation includes select ingredients chosen to align with healthy routines and support individuals seeking help managing non-hunger-related snacking behaviors. Each purchase of ProZenith is covered by a 60-day refund policy, reflecting the company's customer-first return assurance framework. All ProZenith supplements are manufactured without genetically modified ingredients and adhere to U.S. quality standards. Production takes place in an FDA-registered facility that complies with current Good Manufacturing Practices (cGMP). ProZenith is currently available through the company's official online platform at with multiple purchase options provided for convenience. About ProZenith ProZenith develops nutritional supplements designed to support individuals on their wellness journeys. The company emphasizes high-quality manufacturing, transparency, and customer satisfaction as it continues to expand its product offerings for health-conscious consumers. For customer support inquiries, contact:support@ Disclaimer:This product has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Media Contact: Company: ProZenith Address: 19655 E 35th Dr #100, Aurora, CO 80011 Email: support@ Order Phone Support: (925) 217-7353 CONTACT: Company: ProZenith Address: 19655 E 35th Dr #100, Aurora, CO 80011 Email: support@ Order Phone Support: (925) 217-7353Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Egg Recall Map Shows Warnings Issued to Customers in 9 States
Egg Recall Map Shows Warnings Issued to Customers in 9 States

Newsweek

time4 hours ago

  • Newsweek

Egg Recall Map Shows Warnings Issued to Customers in 9 States

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. August Egg Company has issued a recall on Friday for 1,700,000 brown cage-free and certified organic brown eggs due to potential fears of salmonella. Newsweek reached out to the company after hours via phone Friday night for comment. Why It Matters Numerous recalls have been initiated this year due to the potential for the following: damaged products, foodborne illness, contamination and undeclared food allergens. Millions of Americans experience food sensitivities or food allergies every year. According to the Food and Drug Administration (FDA), the nine "major" food allergens in the U.S. are eggs, milk, fish, wheat, soybeans, Crustacean shellfish, sesame, tree nuts and peanuts. The FDA warns that salmonella is an organism that could cause serious and sometimes fatal infections in frail or older people, young children and those with weakened immune systems. What To Know The FDA says in its alert that some of the eggs were distributed to grocery stores including Save Mart, FoodMaxx, Lucky, Smart & Final, Safeway, Raleys, Food 4 Less and Ralphs. Those eggs were distributed from February 3, 2025, to May 15, 2025, with sell by dates of March 4, 2025, and June 4, 2025, in both California and Nevada. The FDA says additional eggs were distributed from February 3, 2025, to May 6, 2025, with sell by dates of March 4, 2025, and June 19, 2025, in Walmart stores in Illinois, Indiana, Nebraska, New Mexico, California, Washington, Nevada, Arizona and Wyoming. The plant code numbers for the recalled eggs can be found printed on the package and are P-6562 or CA5330 with Julian Dates from 32 to 126, the FDA says. The Julian Dates are codes of three to seven digits and represent the date that the food was packaged or manufactured. "This recall is associated with an ongoing outbreak investigation of Salmonella Enteritidis illnesses" the alert says, adding the investigation is related to products distributed in the nine states. The FDA alert also has a chart of the Julian Dates with corresponding item names. What People Are Saying The FDA alert, in part: "August Egg Company is not selling fresh shell eggs at this time. Our firm has voluntarily been diverting eggs to an egg-breaking plant for over 30 days, which pasteurizes the eggs and kills any potential foodborne pathogens." August Egg Company in the FDA alert: "August Egg Company of Hilmar, CA is voluntarily recalling 1,700,000 dozen shell eggs processed at our California plant and sold to various grocery customers. This recall has been initiated due to possible Salmonella enteritidis contamination, which poses a health risk. With that in mind, we believe it is appropriate out of an abundance of caution to conduct this voluntary recall, as consumers may still have these eggs in their homes. "It is important to know that when our processing plant identified this concern, we immediately began diverting all eggs from the plant to an egg-breaking facility, which pasteurizes the eggs and kills any pathogens. "August Egg Company's internal food safety team also is conducting its own stringent review to identify what measures can be established to prevent this situation from recurring. We are committed to addressing this matter fully and to implementing all necessary corrective actions to ensure this does not happen again." What Happens Next Customers with additional questions can call August Egg Company at 1-800-710-2554 from 9 a.m. and 5 p.m. PT and can also return the eggs to the original place of purchase for a refund.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store